SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-020584
Filing Date
2024-05-20
Accepted
2024-05-20 10:12:45
Documents
53
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 568464
2 ex31-1.htm EX-31.1 15171
3 ex31-2.htm EX-31.2 15102
4 ex32-1.htm EX-32.1 6348
5 ex32-2.htm EX-32.2 6345
  Complete submission text file 0001493152-24-020584.txt   3373757

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE acut-20240331.xsd EX-101.SCH 22923
7 XBRL CALCULATION FILE acut-20240331_cal.xml EX-101.CAL 30760
8 XBRL DEFINITION FILE acut-20240331_def.xml EX-101.DEF 94356
9 XBRL LABEL FILE acut-20240331_lab.xml EX-101.LAB 226748
10 XBRL PRESENTATION FILE acut-20240331_pre.xml EX-101.PRE 173884
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 486335
Mailing Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001 442070661000
Accustem Sciences Inc. (Filer) CIK: 0001850767 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56257 | Film No.: 24962800
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)